tiprankstipranks
Statera BioPharma (STAB)
OTHER OTC:STAB
US Market

Statera BioPharma (STAB) Financial Statements

Compare
189 Followers

Statera BioPharma Financial Overview

Statera BioPharma's market cap is currently $7.14K. The company's EPS TTM is $; its P/E ratio is ―; Statera BioPharma is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 21Dec 20Dec 19Dec 18
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ -488.31K$ 0.00$ 0.00$ 0.00
Operating Income$ -98.34M$ -10.50M$ -2.81M$ -4.80M
EBITDA$ 38.93M$ -2.59M$ -2.36M$ -4.80M
Net Income$ -174.41M$ -13.22M$ -3.35M$ -3.61M
Balance Sheet
Cash & Short-Term Investments$ 1.98M$ 593.87K$ 1.65K$ 4.12M
Total Assets$ 21.17M$ 1.04M$ 1.65K$ 4.53M
Total Debt$ 16.26M$ 2.00M$ 1.80M$ 0.00
Net Debt$ 14.42M$ 1.41M$ 1.80M$ -3.62M
Total Liabilities$ 22.68M$ 4.69M$ 4.21M$ 920.38K
Stockholders' Equity$ -1.57M$ -3.66M$ -4.21M$ -1.45M
Cash Flow
Free Cash Flow$ -28.38M$ -5.09M$ -240.37K$ -4.61M
Operating Cash Flow$ -28.19M$ -5.08M$ -240.37K$ -4.61M
Investing Cash Flow$ 13.46M$ -9.64K$ 156.78K$ 3.97M
Financing Cash Flow$ 20.99M$ 5.68M$ 231.00K$ 55.22K
Currency in USD

Statera BioPharma Earnings and Revenue History

Statera BioPharma Debt to Assets

Statera BioPharma Cash Flow

Statera BioPharma Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis